MedTrace Logo

Dispervise Ophthalmic Viscoelastic as an Agent to Ensure Watertight Wound Closure After Clear Corneal Cataract Incisions

NCT01298973 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2012-01-18

No results posted yet for this study

Summary

The purpose of this study is to look at the ability of Viscoat to ensure proper wound closure.

Conditions

  • Cataracts

Interventions

DRUG

Viscoat

One group will receive Viscoat for incision closure

DRUG

Saline

One group will receive Saline to irrigate the wound

Sponsors & Collaborators

  • Innovative Medical

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2012-01-31
Completion
2012-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01298973 on ClinicalTrials.gov